Amoxicillin Alone is Appropriate First-Line Therapy for Uncomplicated Acute Bacterial Sinusitis
For most adults with uncomplicated acute bacterial sinusitis, amoxicillin alone (without clavulanate) is an appropriate and effective first-line antibiotic choice. The most recent 2025 guideline explicitly recommends "amoxicillin with or without clavulanate" as first-line therapy 1, 2, and the highest quality recent evidence from 2026 demonstrates no difference in treatment failure between the two options 3.
When to Use Amoxicillin vs Augmentin
Start with Amoxicillin Alone if:
- Patient has uncomplicated acute bacterial sinusitis (symptoms ≥10 days or worsening after initial improvement)
- No recent antibiotic use (within past 30 days)
- No high-risk features for resistant organisms
- Mild to moderate severity
- Age ≥2 years (for children)
- Not attending daycare (for children)
Dosing: Standard-dose amoxicillin 875 mg twice daily for adults 4, 5
Use Amoxicillin-Clavulanate (Augmentin) if:
- Recent antibiotic exposure (within 30 days)
- Moderate to severe illness at presentation (severe pain or fever ≥38.3°C/101°F) 6
- Treatment failure after 3-5 days on amoxicillin 7, 2
- High local resistance to amoxicillin (>10% nonsusceptible S. pneumoniae or high β-lactamase-producing H. influenzae) 8
- Age <2 years or daycare attendance (for children) 8
- Comorbidities that increase risk (though recent 2026 evidence challenges this) 9
Dosing: High-dose amoxicillin-clavulanate 2000 mg/125 mg twice daily for adults 4, 5
Evidence Supporting Amoxicillin Alone
The 2026 JAMA study 3—the most recent and highest quality evidence—compared standard-dose amoxicillin-clavulanate versus amoxicillin in over 234,000 propensity-matched adults with acute sinusitis. Treatment failure rates were identical (3.0% vs 3.1%), with no difference in emergency department visits or hospitalizations. Critically, amoxicillin-clavulanate was associated with significantly higher rates of adverse events, including yeast infections (1.1% vs 0.8%) and C. difficile infections (0.04% vs 0.02%).
A second 2026 study 9 in adults with comorbidities found no significant difference in treatment failure between amoxicillin and amoxicillin-clavulanate, supporting narrow-spectrum therapy even in higher-risk patients. Similarly, a 2021 Veterans Affairs study 10 of nearly 90,000 patients showed equivalent efficacy (4.9% vs 5.1% return visits) but fewer gastrointestinal adverse events with amoxicillin (0.5% vs 0.7%).
Guideline Evolution
The 2025 AAO-HNS guideline 1, 2 represents an important shift from the 2015 version 4, 5, now explicitly stating "amoxicillin with or without clavulanate" rather than preferencing one over the other. This change reflects accumulating evidence that amoxicillin alone is sufficient for most cases. Earlier guidelines from 2005 7 and 2007 6 consistently identified amoxicillin as "the drug of choice" for initial therapy, reserving amoxicillin-clavulanate for treatment failures or high-resistance areas.
Treatment Algorithm
Diagnose ABRS: Symptoms ≥10 days OR worsening after initial improvement ("double worsening") 1, 2
Consider watchful waiting (3-5 days without antibiotics) for all patients with assured follow-up 1, 2
If prescribing antibiotics:
Reassess at 3-5 days: If no improvement or worsening, switch to high-dose amoxicillin-clavulanate 7, 2
Duration: 5-10 days total (shorter courses may be equally effective) 4, 5
Common Pitfalls
Over-prescribing amoxicillin-clavulanate: The clavulanate component adds cost, adverse effects (especially diarrhea), and broader spectrum coverage without improving outcomes in uncomplicated cases 3, 10
Ignoring local resistance patterns: In areas with >10% nonsusceptible S. pneumoniae or high β-lactamase-producing H. influenzae, consider starting with amoxicillin-clavulanate 8
Premature treatment failure assessment: Wait at least 3-5 days before declaring treatment failure, as fluctuations in symptoms within 48-72 hours are common 2
Not considering watchful waiting: Many patients improve spontaneously; antibiotics provide only modest incremental benefit (91% vs 86% cure rates) 4
Penicillin Allergy
For true penicillin allergy, alternatives include:
- Trimethoprim-sulfamethoxazole (adults)
- Macrolides (azithromycin, clarithromycin)
- Fluoroquinolones (levofloxacin, moxifloxacin)
- Cephalosporins (if no severe/immediate hypersensitivity) 7, 6
Bottom Line
Amoxicillin alone is the preferred first-line antibiotic for uncomplicated acute bacterial sinusitis in adults, offering equivalent efficacy to amoxicillin-clavulanate with fewer adverse events and lower cost 3, 10. Reserve Augmentin for treatment failures, recent antibiotic use, severe illness, or documented high local resistance patterns 7, 1, 2.